Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Tacrolimus
Related studies linked through entity extraction aliases.
Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection
- Status
- COMPLETED
- Phase
- PHASE2
Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE4
Campath-1H + FK506 and Methylprednisolone for GVHD
- Status
- COMPLETED
- Phase
- PHASE2
A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy
- Status
- COMPLETED
- Phase
- PHASE4
Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients
- Status
- COMPLETED
- Phase
- PHASE2
Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE4
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
- Status
- COMPLETED
- Phase
- PHASE2
Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE3
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders
- Status
- COMPLETED
- Phase
- PHASE2
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE2